Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DOY1D6
|
|||
| Drug Name |
HTI-2088
|
|||
| Indication | Type 2 diabetes [ICD-11: 5A11; ICD-10: E08-E13] | Phase 1 | [1] | |
| Company |
Hengrui Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03203811) A Phase 1, Study to Evaluate HTI-2088 Tablet. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.